跳至主要内容
临床试验/2024-515260-31-00
2024-515260-31-00已完成4 期

proMoting Effective Renoprotection in Cardiac sURgery patients by Inhibition of SGLT-2

Stichting Amsterdam UMC7 个研究点 分布在 1 个国家目标入组 784 人开始时间: 2024年6月25日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
784
试验地点
7
主要终点
Incidence of AKI within 7 days after surgery, satisfying KDIGO criteria.

研究概览

简要总结

Prevent AKI

入排标准

年龄范围
18 years 至 65+ years(18-64 Years, 65+ Years)
接受健康志愿者

入选标准

  • > 18 years-old
  • Undergoing elective cardiac surgery with cardio-pulmonary bypass (CPB) or off-pump coronary artery bypass surgery (OPCAB).
  • Providing informed consent

排除标准

  • Current treatment with SGLT2 inhibitors
  • Reduced kidney function at baseline with eGFR < 20 ml/min at time of inclusion
  • Diabetes Mellitus Type 1
  • History of diabetic keto acidosis
  • Diabetes Mellitus Type 2 with BMI<25 for people with type 2 diabetes who are using multiple daily insulin injections (both short and long-acting insulin)
  • Systolic blood pressure < 100 mmHg at time of inclusion
  • Emergency surgery, defined as in need of surgery for medical reasons < 7 days, i.e. “S1- 4” according to the Amsterdam UMC classification
  • Female of child-bearing potential who is pregnant, breast-feeding or intend to become pregnant or is not using adequate contraceptive methods
  • Known or suspected allergy to trial products or other drugs in the same class

结局指标

主要结局

Incidence of AKI within 7 days after surgery, satisfying KDIGO criteria.

Incidence of AKI within 7 days after surgery, satisfying KDIGO criteria.

次要结局

  • Stage 3 AKI according to KDIGO criteria
  • Postoperative maximum change of eGFR compared to the baseline eGFR
  • De novo postoperative atrial fibrillation, registered on a 12-lead ECG
  • LoS-ICU: Length of Stay in the Intensive Care Unit, measured in days
  • LoS-Hos: Length of Stay in Hospital, measured in days
  • MAKE: Major Adverse Kidney Events. Composite endpoint of death, new dialysis, and worsened renal function
  • MACE: Major Adverse Cardiovascular Events. Composite endpoint of cardiovascular death, nonfatal myocardial infarction (MI), nonfatal ischaemic cerebral vascular accident (iCVA) and hospitalization for heart failure
  • Patient reported quality of recovery (QoR), according to the following three questionnaires: o DAH30: Days at Home in first 30 days o WHO-DAS 2.0: World Health Organisation Disability Assessment Schedule 2.0 o EQ5D5L: 5 level EuroQol 5D questionnaire: a standardised measure of health status developed by the EuroQol Group to provide a simple, generic measure of health for clinical and economic appraisal
  • Safety outcomes: genital mycotic infections, diabetic keto-acidosis, and hypoglycaemia, in addition to incidence of postoperative complications and Serious Adverse Events (SAEs)
  • Healthcare costs and productivity costs will be objectified to weigh cost-effectiveness, using the following two questionnaires: o iPCQ: IMTA (Institute for Medical Technology Assessment) Productivity Cost Questionnaire. o IMCQ: IMTA (Institute for Medical Technology Assessment) Medical Consumption Questionnaire.
  • Peri-operative glucose measurements (routinely measured in clinical setting): average daily glucose, incidence of hypoglycaemia (blood glucose < 4 mmol/l) and hyperglycaemia (blood glucose > 10 mmol/l)
  • Peri-operative heamodynamic vital signs (routinely measured in clinical setting).
  • Postoperative of cardiac function (echocardiography and cardiac biomarkers) routinely carried out in clinical practice
  • Urine oxygenation measured with an oxygen sensor placed in the urinary catheter: mean intraoperative urine oxygenation, change from baseline and mean postoperative urine oxygenation. Frequency and duration of monitor interruptions. Correlation in time between deprived urine oxygenation and current AKI markers.

研究者

申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Daniël van Raalte

Scientific

Stichting Amsterdam UMC

研究点 (7)

Loading locations...

相似试验